Cargando…

Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish

BACKGROUND: Mycobacterium abscessus is a non-tuberculous mycobacterium (NTM) that causes chronic pulmonary infections. Because of its extensive innate resistance to numerous antibiotics, treatment options are limited, often resulting in poor clinical outcomes. Current treatment regimens usually invo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goh, Boon Chong, Larsson, Simon, Dam, Linh Chi, Ling, Yan Han Sharon, Chua, Wei Lin Patrina, Abirami, R, Singh, Samsher, Ong, Jun Long Ernest, Teo, Jeanette W P, Ho, Peiying, Ingham, Philip W, Pethe, Kevin, Dedon, Peter C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164658/ https://www.ncbi.nlm.nih.gov/pubmed/37168836 http://dx.doi.org/10.1093/jacamr/dlad052

Ejemplares similares

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
por: Mukherjee, Devika, et al.
Publicado: (2017)

In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex
por: Chew, Ka Lip, et al.
Publicado: (2021)

Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex
por: Rubio, Marc, et al.
Publicado: (2015)

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021)

The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex
por: Takei, Satomi, et al.
Publicado: (2020)

The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin
por: Vianna, Júlia S., et al.
Publicado: (2019)

Unusually high clarithromycin resistance in Mycobacterium abscessus subsp. abscessus isolated from human gastric epithelium
por: Chouhan, Deepak, et al.
Publicado: (2023)

Pulmonary Mycobacterium abscessus Subspecies abscessus Disease That Showed a Discrepancy Between the Genotype and Phenotype of Clarithromycin Resistance
por: Yamaba, Yusuke, et al.
Publicado: (2019)

Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates
por: Guo, Qi, et al.
Publicado: (2020)

The Clarithromycin Susceptibility Genotype Affects the Treatment Outcome of Patients with Mycobacterium abscessus Lung Disease
por: Guo, Qi, et al.
Publicado: (2018)

Lack of association between rrl and erm(41) mutations and clarithromycin resistance in Mycobacterium abscessus complex
por: Carneiro, Maiara dos Santos, et al.
Publicado: (2017)

Genetic Evolution of Mycobacterium abscessus Conferring Clarithromycin Resistance during Long-Term Antibiotic Therapy
por: Li, Bing, et al.
Publicado: (2020)

Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus
por: Sudadech, Phantitra, et al.
Publicado: (2021)

A real-time PCR assay for rapid identification of inducible and acquired clarithromycin resistance in Mycobacterium abscessus
por: Sharma, Meenu Kaushal, et al.
Publicado: (2020)

Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis
por: Li, Haoran, et al.
Publicado: (2022)

Aortic endograft infection by Mycobacterium abscessus subsp. massiliense with acquired clarithromycin resistance: a case report
por: Akiyama, Yutaro, et al.
Publicado: (2023)

Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay
por: Portell-Buj, Elena, et al.
Publicado: (2021)

Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
por: Aziz, Dinah B., et al.
Publicado: (2018)

Rifabutin Is Active against Mycobacterium abscessus Complex
por: Aziz, Dinah Binte, et al.
Publicado: (2017)

Rifabutin Suppresses Inducible Clarithromycin Resistance in Mycobacterium abscessus by Blocking Induction of whiB7 and erm41
por: Aziz, Dinah Binte, et al.
Publicado: (2020)

PCR amplification of the erm(41) gene can be used to predict the sensitivity of Mycobacterium abscessus complex strains to clarithromycin
por: Mase, Ayaka, et al.
Publicado: (2020)

Detection and Assessment of Clarithromycin Inducible Resistant Strains Among Korean Mycobacterium abscessus Clinical Strains: PCR Methods
por: Lee, Seung‐Heon, et al.
Publicado: (2014)

Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination
por: Pryjma, Mark, et al.
Publicado: (2018)

Assessment of antimycobacterial activities of pure compounds extracted from Thai medicinal plants against clarithromycin-resistant Mycobacterium abscessus
por: Sirichoat, Auttawit, et al.
Publicado: (2021)

Severe Pulmonary Mycobacterium abscessus Cases Due to Co-Infection with Other Microorganisms Well Treated by Clarithromycin and Sitafloxacin in Japan
por: Takano, Kazuki, et al.
Publicado: (2021)

Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the whiB7 Gene
por: Pryjma, Mark, et al.
Publicado: (2017)

Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus
por: Khosravi, Azar Dokht, et al.
Publicado: (2018)

Tedizolid Activity Against Clinical Mycobacterium abscessus Complex Isolates—An in vitro Characterization Study
por: Tang, Ying Wei, et al.
Publicado: (2018)

Molecular epidemiology and phylogenomic analysis of Mycobacterium abscessus clinical isolates in an Asian population
por: Chew, Ka Lip, et al.
Publicado: (2021)

Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Current status of Helicobacter pylori resistance to Clarithromycin and Levofloxacin in Malaysia—findings from a molecular based study
por: Puah, Suat Moi, et al.
Publicado: (2021)

Rifaximin Therapy of Irritable Bowel Syndrome
por: Koo, Hoonmo L., et al.
Publicado: (2012)

Rifaximin, Microbiota Biology, and Hepatic Encephalopathy
por: Peleman, Cedric, et al.
Publicado: (2016)

Rifaximin for Pertuzumab-Related GI Toxicities
por: Soyano, Aixa E., et al.
Publicado: (2017)

Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans
por: Finlin, Brian S, et al.
Publicado: (2019)

Canaliculitis por Mycobacterium abscessus subsp. abscessus
por: Tello, María Nieves Carmona, et al.
Publicado: (2021)

Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand
por: Ananta, Pimjai, et al.
Publicado: (2018)

Rifaximin for maintenance therapy in antibiotic-dependent pouchitis
por: Shen, Bo, et al.
Publicado: (2008)

The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea
por: Koo, Hoonmo L, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gum0atft7ngpfgmdk0inteb1f6